Skip to content

Amplatzer™ Vascular Plug 4 (REF 9-AVP038-006)Recalls & reported problems

Aga Medical Corporation · Vascular Plug 4 · Class 2 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00811806012360), received between Jun 16, 2023 and Dec 5, 2023 — classified as 2 injuries.

The most frequently reported specific device problem is “Difficult to Fold, Unfold or Collapse” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 1 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Difficult to Fold, Unfold or Collapse1
  • Fracture1
  • Improper or Incorrect Procedure or Method1
  • Migration or Expulsion of Device1
  • Off-Label Use1
  • Separation Problem1

Patient problems

  • Foreign Body In Patient1
  • Insufficient Information1
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 5, 2023Migration or Expulsion of Device; Off-Label Use; Migration or Expulsion of Device; Off-Label Use

    THE ARTICLE, ¿RISK FACTORS ASSOCIATED WITH DEVICE EMBOLISATION OR MALPOSITION DURING TRANSCATHETER CLOSURE OF PATENT DUCTUS ARTERIOSUS¿, WAS REVIEWED. THE ARTICLE PRESENTED A CASE STUDY OF A 1 MONTH OLD PATIENT WEIGHING 2.1 KG THAT WAS BORN PRE-TERM. IT WAS REPORTED THAT ON AN UNKNOWN DATE, A 6MM AMPLATZER VASCULAR PLUG IV WAS CHOSEN FOR IMPLANT TO TREAT PATENT DUCTUS ARTERIOSUS (PDA) THAT WAS SIZED 4 MM. IT WAS THEN REPORTED ON AN UNKNOWN DATE, THE DEVICE HAD EMBOLIZED AND A DECISION WAS MADE TO RETRIEVE THE DEVICE VIA TRANSCATHETER SNARE AND REPLACE WITH AN 8MM AMPLATZER VASCULAR PLUG II. AFTER INTERVENTION PROCEDURE, IT WAS REPORTED THE PATIENT DEVELOPED LEFT PULMONARY STENOSIS. THE ARTICLE CONCLUDED DEVICE EMBOLISATION COMPLICATES 4% OF TRANSCATHETER DUCT CLOSURES, WITH NEED FOR SURGERY IN ONE-FIFTH OF THEM. LARGER DUCTS WITH HIGH PULMONARY ARTERY PRESSURES IN YOUNGER AND SMALLER INFANTS ARE MORE OFTEN ASSOCIATED WITH DEVICE EMBOLISATION. TUBULAR DUCTS ARE MORE PRONE FOR EMBOLISATION COMPARED TO USUAL CONICAL DUCTS. SOFTER VASCULAR PLUGS ARE OFTEN ASSOCIATED WITH EMBOLISATIONS. INTENTIONAL DEVICE UNDERSIZING TO AVOID VASCULAR OBSTRUCTION IN SMALL PATIENTS IS A FREQUENT RISK FAC

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18268497 ↗
  • InjuryJun 16, 2023Difficult to Fold, Unfold or Collapse; Fracture; Improper or Incorrect Procedure or Method; Separation Problem; Difficult to Fold, Unfold or Collapse; Fracture; Improper or Incorrect Procedure or Method; Separation Problem

    IT WAS REPORTED THAT ON (B)(6) 2023, A 6MM AMPLATZER VASCULAR PLUG IV WAS SELECTED FOR AN IMPLANT. DURING THE PROCEDURE, THERE WAS ISSUE WITH THE PLUG. IT WAS IMPOSSIBLE TO DETACH THE PLUG AND IMPOSSIBLE TO RETRACT THE PLUG AFTER DEPLOYMENT IN THE LEFT GONADAL VEIN. THE DELIVERY WIRE WAS LEFT IN PLACE (LEFT GONADAL VEIN, LEFT RENAL VEIN, LEFT CAVE VEIN, RIGHT ILIAC VEIN AND RIGHT COMMON FEMORAL VEIN) AND SECURED IN THE RIGHT ILIAC VEIN WITH A STENT TO LIMIT RISK OF SECONDARY MIGRATION. THE PATIENT DID NOT HAVE A TORTUOUS ANATOMY. THE PLUG WAS NOT DEFORMED/DAMAGED/ DURING PROCEDURE. AN ANTIAGGREGANT TREATMENT WILL BE APPLIED TO THE PATIENT FOR 6 MONTHS POST PROCEDURE TO LIMIT THE RISK OF VENOUS THROMBOSIS AT THE RENAL VEIN, RISK OF COMPLICATION AT THE LOWER MEMBER, RISK OF MIGRATION IN THE HEART. THE PROCEDURE TIME WAS EXTENDED TO A TOTAL TIME OF 3 HOURS. PATIENT STATUS WAS REPORTED AS STABLE. NO ADDITIONAL INFORMATION PROVIDED. ON 18 AUGUST 2023, ADDITIONAL INFORMATION RECEIVED; THE PLUG REMAINED IMPLANTED AT THE TARGET LESION AND REMAINED ATTACHED TO THE DISTAL PART OF THE CABLE. PART OF THE CABLE WITH THE PLUG AND LEFT IN THE PATIENT. THE CABLE IS MAINTAINED BY THE PLUG DISTALLY

    Patient problems: Foreign Body In Patient; Insufficient Information

    MAUDE report 17148744 ↗

Other Device, Vascular, for Promoting Embolization devices

All Device, Vascular, for Promoting Embolization devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page